These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4439375)

  • 21. The activity state of factor VII in plasma: two pathways for the cold promoted activation of factor VII.
    Muller AD; van Deijk WA; Devilée PP; van Dam-Mieras MC; Hemker HC
    Br J Haematol; 1986 Feb; 62(2):367-77. PubMed ID: 3484966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conversion of Hageman factor (factor XII) of the guinea pig to prekallikrein activator and inhibition of the formed kallikrein by a natural plasma inhibitor.
    Takeuchi Y; Movat HZ
    Eur J Immunol; 1972 Aug; 2(4):345-9. PubMed ID: 4538864
    [No Abstract]   [Full Text] [Related]  

  • 23. Cold promoted activation of factor VII. IV. Relation to the coagulation system.
    Gjonnaess H
    Thromb Diath Haemorrh; 1972 Oct; 28(2):194-205. PubMed ID: 4639653
    [No Abstract]   [Full Text] [Related]  

  • 24. Interactions among Hageman factor (HG, Factor XII), plasma thromboplastin antecedent (PTA, Factor XI), plasma prekallikrein (PK, Fletcher factor) and high molecular weight kininogen (HMW-K, Fitzgerald factor) in blood coagulation.
    Saito H; Ratnoff OD
    Adv Exp Med Biol; 1979; 120B():61-70. PubMed ID: 517254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and physiologic studies of two siblings with prekallikrein (Fletcher factor) deficiency.
    Hathaway WE; Wuepper KD; Weston WL; Humbert JR; Rivers RP; Genton E; August CS; Montgomery RR; Mass MF
    Am J Med; 1976 May; 60(5):654-64. PubMed ID: 1020754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of a coagulation assay determining the activity state of factor VII in plasma.
    van Deijk WA; van Dam-Mieras MC; Muller AD; Hemker HC
    Haemostasis; 1983; 13(3):192-7. PubMed ID: 6604003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.
    Revak SD; Cochrane CG; Griffin JH
    J Clin Invest; 1977 Jun; 59(6):1167-75. PubMed ID: 864009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abnormalities in the contact activation through factor XII in Fujiwara trait: a deficiency in both high and low molecular weight kininogens with low level of prekallikrein.
    Oh-ishi S; Ueno A; Uchida Y; Katori M; Hayashi H; Koya H; Kitajima K; Kimura I
    Tohoku J Exp Med; 1981 Jan; 133(1):67-80. PubMed ID: 6785899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interactions among Hageman factor, plasma prekallikrein, high molecular weight kininogen, and plasma thromboplastin antecedent.
    Ratnoff OD; Saito H
    Proc Natl Acad Sci U S A; 1979 Feb; 76(2):958-61. PubMed ID: 284420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prekallikrein (Fletcher factor) deficiency in clinical disease states.
    Ragni MV; Lewis JH; Hasiba U; Spero JA
    Thromb Res; 1980 Apr 1-15; 18(1-2):45-54. PubMed ID: 6902559
    [No Abstract]   [Full Text] [Related]  

  • 31. Cold-promoted activation of factor VII in human plasma: studies on the associated acyl-arginine esterase activity.
    Laake K; Venneröd AM; Haugen G; Gjönnaess H
    Thromb Res; 1974 Jun; 4(6):769-85. PubMed ID: 4844061
    [No Abstract]   [Full Text] [Related]  

  • 32. Activation of factor XII and prekallikrein with cholesterol sulfate.
    Shimada T; Kato H; Iwanaga S; Iwamori M; Nagai Y
    Thromb Res; 1985 Apr; 38(1):21-31. PubMed ID: 3847226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fletcher factor deficiency: report of a new family.
    Aznar JA; España F; Aznar J; Tascon A; Jimenez C
    Scand J Haematol; 1978 Aug; 21(2):94-8. PubMed ID: 694428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cold promoted activation and factor XII, prekallikrein and C1-inhibitor.
    Czendlik C; Lämmle B; Duckert F
    Thromb Haemost; 1985 Apr; 53(2):242-4. PubMed ID: 2410997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Determination of factor XII, plasma prekallikrein and factor V in patients with thrombophilic states].
    Stürzebecher J; Huyke R; Vogel G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):492-6. PubMed ID: 6083916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation and characterization of a prealbumin activator of prekallikrein from acetone-activated human plasma.
    Venneröd AM; Laake K
    Thromb Res; 1974 Jan; 4(1):103-18. PubMed ID: 4829662
    [No Abstract]   [Full Text] [Related]  

  • 37. FIBRINOLYSIS AND FORMATION OF BIOLOGICALLY ACTIVE POLYPEPTIDES.
    EISEN V
    Br Med Bull; 1964 Sep; 20():205-9. PubMed ID: 14209760
    [No Abstract]   [Full Text] [Related]  

  • 38. Prekallikrein and plasminogen proactivator: absence of plasminogen proactivator in Fletcher factor deficient plasma.
    Venneröd AM; Laake K
    Thromb Res; 1976 Apr; 8(4):519-22. PubMed ID: 1273811
    [No Abstract]   [Full Text] [Related]  

  • 39. Prekallikrein (Fletcher factor) deficiency in typhoid fever.
    Beard ME; Hickton CM
    Arch Intern Med; 1981 Nov; 141(12):1701-3. PubMed ID: 6914157
    [No Abstract]   [Full Text] [Related]  

  • 40. Enhanced specificity of immunoblotting using radiolabeled antigen overlay: studies of blood coagulation factor XII and prekallikrein in plasma.
    Lämmle B; Berrettini M; Griffin JH
    Anal Biochem; 1986 Jul; 156(1):118-25. PubMed ID: 3638135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.